B

Bergstrom Eye Research | Fargo, ND

Research site

(Unclaimed)

Location

2607 S University Drive, Fargo, North Dakota, United States of America

Site insights

Top conditions

Top treatments

Bimatoprost

SAF312

TOUR006

MELT-300

ZOC2017217

ADX-102

Pilocarpine

Dexamethasone Sodium Phosphate

PL9643

RGN-259

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 20 total trials

Locations recently updated

A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract

This is a multicenter, randomized, double-masked, placebo-controlled pilot study conducted in the United States (US) in subjects with age-related cat...

Enrolling

Age Related Cataracts

Drug: Control

Drug: 0.4% ZOC2017217

A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

The goal of this clinical trial is to learn if MELT-300 works on procedural sedation in adult participants undergoing cataract extraction with lens r...

Enrolling

Cataract

Drug: MELT-300 sublingual tablet

Drug: Placebo sublingual tablet

A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease (spiriTED)

Phase 2b trial of TOUR006 in Thyroid Eye Disease (TED) to evaluate 20mg and 50mg doses against placebo given by a subcutaneous injection every eight...

Active, not recruiting

Thyroid Eye Disease

Other: Placebo

Drug: TOUR006 - 50 MG